Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 67, Issue 2, Pages 505-513
Publisher
Wiley
Online
2017-09-02
DOI
10.1002/hep.29510
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of Ledipasvir Plus Sofosbuvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2 Infection
- (2017) Edward J. Gane et al. GASTROENTEROLOGY
- CERTAIN-1: efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis
- (2017) K. Chayama et al. JOURNAL OF HEPATOLOGY
- EXPEDITION-I: efficacy and safety of glecaprevir/pibrentasvir in adults with chronic hepatitis C virus genotype 1, 2, 4, 5 or 6 infection and compensated cirrhosis
- (2017) X. Forns et al. JOURNAL OF HEPATOLOGY
- High SVR rates with eight and twelve weeks of pangenotypic glecaprevir/pibrentasvir: integrated efficacy and safety analysis of genotype 1–6 patients without cirrhosis
- (2017) M. Puoti et al. JOURNAL OF HEPATOLOGY
- Review article: safety and tolerability of direct-acting anti-viral agents in the new era of hepatitis C therapy
- (2016) D. Banerjee et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectives
- (2016) Tarik Asselah et al. LIVER INTERNATIONAL
- A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan
- (2015) Heather Bennett et al. Hepatology International
- Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
- (2015) Jordan J. Feld et al. NEW ENGLAND JOURNAL OF MEDICINE
- Global distribution and prevalence of hepatitis C virus genotypes
- (2014) Jane P. Messina et al. HEPATOLOGY
- Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial
- (2014) Masao Omata et al. JOURNAL OF VIRAL HEPATITIS
- Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence
- (2012) Khayriyyah Mohd Hanafiah et al. HEPATOLOGY
- Treatment of chronic hepatitis C virus infection in Japan: update on therapy and guidelines
- (2012) Kazuaki Chayama et al. JOURNAL OF GASTROENTEROLOGY
- The Burden of Illness for Patients with Viral Hepatitis C: Evidence from a National Survey in Japan
- (2012) Gordon G. Liu et al. VALUE IN HEALTH
- A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt
- (2011) William Sievert et al. LIVER INTERNATIONAL
- Changing Trends in Hepatitis C Infection over the Past 50 Years in Japan
- (2010) Hobyung Chung et al. INTERVIROLOGY
- Treatment of chronic hepatitis C in Asia: When East meets West
- (2009) Ming-Lung Yu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started